register

Leadership & Management

AICD and Governance Institute launch new report: Governance through a crisis

Health Industry Hub | September 14, 2020 |

Leadership & Management: The Australian Institute of Company Directors (AICD) and the Governance Institute of Australia have published a new report about the impact of COVID-19 on board practices and insights into the governance challenges in the current climate.

The Governance through a crisis: Learning from COVID-19 report, includes insights from interviews with senior directors, survey responses and feedback from roundtables with governance and risk professionals.

The research reveals that the pandemic has had a profound impact on how boards operate and what they focus on. It is hoped this research will help to develop stronger organisational resilience and serve as a practical resource applicable to all sectors – from not-for-profits to ASX listed companies.

The insights about governing through the COVID-19 crisis explored in this report include:

  1. How boards have successfully adapted to virtual meetings, including AGMs
  2. The need for agile decision-making in a crisis
  3. The importance of contingency planning
  4. How technology can elevate stakeholder voices

The report includes recommendations for directors and company secretaries as well as practical tips for working effectively in the virtual environment and through a crisis.

AICD CEO and Managing Director, Angus Armour, said “The business community has seen profound changes to board practices and processes in response to the challenges brought about by COVID-19.

“Our conversations with directors and research have shown us that the rolling uncertainty of the pandemic compelled boards and organisations to adapt and innovate. Boards and organisations should reflect on the lessons from this period and what they mean for future governance practices.

“To accelerate Australia’s economic recovery, our laws and regulatory settings need to reflect the modernisations embraced by organisations. These include laws around virtual AGMs, e-signatures and electronic notices of meetings.”

Governance Institute of Australia CEO, Megan Motto, said the lessons in the report will be an important part of a board’s arsenal as they emerge from the pandemic, and crisis planning has been highlighted as a key consideration.

“This report, and the lessons that it outlines, is an important resource that will help boards navigate the path out of the pandemic,” Ms Motto said.

“Overwhelmingly businesses rose to the challenges presented by COVID-19 but, as the report highlights, a comprehensive continuity plan was lacking for many and will be essential in order to tackle future crises.

“Planning precisely for a crisis is difficult, but ensuring you have the right scaffolding in place for when a crisis hits must now be a key focus for organisations.”


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.